Evaluating Safety of Andiabet on Diabetes Mellitus Type II Patients, Phase I CT.
Status:
Completed
Trial end date:
2019-02-22
Target enrollment:
Participant gender:
Summary
This phase I clinical trial is used to evaluate the safety of Andiabet, a herbal-derived
medicinal product that assists in the treatment of type 2 Diabetes (T2D). Thereby, determine
efficacy of the drug on stabilizing blood glucose in T2D patients.
Phase:
Phase 1
Details
Lead Sponsor:
Centre of Clinical Pharmacology, Hanoi Medical University